UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Cytotherapy (Oxford, England), 2006, Vol.8 (4), p.315-317

2006

Volltextzugriff (PDF)

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement

Cytotherapy (Oxford, England), 2005, Vol.7 (5), p.393-395

2005

Volltextzugriff (PDF)

Pretreatment Predictors of Receiving Adjuvant Radiation Therapy for Prostate Cancer

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E280-E280

2016

Volltextzugriff (PDF)

Applying ASTRO APEx Guidelines and RO-ILS to Medical Malpractice in Radiation Oncology

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E540-E540

2016

Volltextzugriff (PDF)

Evaluation of Biologically Equivalent Dose Escalation and Patient Outcomes Among International Randomized Controlled Trials of Conventionally Fractionated and Hypofractionated Radiation Therapy: A Meta-Analysis of 6800 Patients

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E201-E202

2015

Volltextzugriff (PDF)

Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM

Cytotherapy (Oxford, England), 2006, Vol.8 (5), p.437-444

2006

Volltextzugriff (PDF)

Preliminary Results of Radiation Therapy Oncology Group 97-03: A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck

Journal of clinical oncology, 2004-07, Vol.22 (14), p.2856-2864

2004

Volltextzugriff (PDF)

Type 2 Diabetes Mellitus, Oral Antihyperglycemics, Insulin Use, and Outcomes Among Men Receiving Radiation Therapy for Prostate Cancer

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E201-E201

2015

Volltextzugriff (PDF)

The Need for Androgen Deprivation Therapy in Patients With Intermediate-Risk Prostate Cancer Treated With Dose-Escalated External Beam Radiation Therapy

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E237-E238

2015

Volltextzugriff (PDF)

Effects of Time to Treatment on Biochemical and Clinical Outcomes for Patients With Prostate Cancer Treated With Definitive Radiation

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E239-E239

2015

Volltextzugriff (PDF)

Quality Adjusted Survival Comparing Standard Versus Hypofractionated Radiation Therapy in the Treatment of Prostate Cancer

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S118-S119

2015

Volltextzugriff (PDF)

Clinical Outcomes for Patients With Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiation Therapy or Radical Prostatectomy: A Comparative Analysis

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E229-E229

2016

Volltextzugriff (PDF)

Dosimetric and Clinical Predictors of Long-Term Toxicity in Patients Undergoing Hypofractionated Prostate Radiation Therapy: Results From a Randomized Phase 3 Trial

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S123-S123

2016

Volltextzugriff (PDF)

Efficacy of Pulsed Low-Dose-Rate Reirradiation: Results From a Phase 1 Clinical Trial

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S147-S147

2016

Volltextzugriff (PDF)

Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E242-E242

2016

Volltextzugriff (PDF)

CT-MRI Fusion Uncertainty in Prostate Treatment Planning for Different Image Guidance Techniques

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S718-S718

2013

Volltextzugriff (PDF)

Men’s Health Supplement Use and Outcomes Among Men Receiving Definitive IMRT for Localized Prostate Cancer

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E194-E195

2015

Volltextzugriff (PDF)

A Multi-institutional Phase 2 Trial Assessing Quality of Life (QOL) After Electromagnetic Transponder Guided Prostate Stereotactic Body Radiation Therapy (SBRT)

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E205-E206

2015

Volltextzugriff (PDF)

Phase I Study of Pulsed Low Dose-Rate Reirradiation: A Dose-Escalation Study to Establish Maximum Tolerated Dose

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E482-E482

2015

Volltextzugriff (PDF)

Long-term Patient Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated IMRT Radiation Therapy for Localized Prostate Cancer

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S34-S35

2015

Volltextzugriff (PDF)

Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer

International journal of radiation oncology, biology, physics, 2016, Vol.94 (1), p.2-2

2016

Volltextzugriff (PDF)

Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG Oncology/RTOG 9202

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S44-S44

2015

Volltextzugriff (PDF)

Nadir Prostate-Specific Antigen After Neoadjuvant Androgen Suppression (AS) in Prostate Cancer Patients Receiving Short-term AS and Radiation Therapy: Pooled Analysis of Four NRG Oncology/RTOG Randomized Clinical Trials

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S46-S46

2015

Volltextzugriff (PDF)

A Novel Methodology to Predict Late Urinary Toxicity Following Prostate Radiation Therapy-based on Bladder Wall Dosimetry

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S418-S419

2012

Volltextzugriff (PDF)

Recursive Partitioning Analysis of Intermediate Risk Prostate Cancer Patients Identifies Subgroup Risk Categories

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S183-S183

2012

Volltextzugriff (PDF)

1 – 25 von 211

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(200)
Mit Volltextzugriff
(190)

Publikationsform

Artikel
(211)

Sprache

Englisch
(211)

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(58)
Radiology
(53)
Science & Technology
(30)
Life Sciences & Biomedicine
(28)
Humans
(27)
Hematology
(15)
Biotechnology & Applied Microbiology
(10)
Cell & Tissue Engineering
(10)
Cell Biology
(10)
Medicine, Research & Experimental
(10)
Research & Experimental Medicine
(10)
Child
(9)
Adolescent
(8)
Biological And Medical Sciences
(8)
Oncology
(8)
Pediatrics
(8)
Adult
(7)
Animals
(7)
Male
(7)
Female
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement

Pretreatment Predictors of Receiving Adjuvant Radiation Therapy for Prostate Cancer

Applying ASTRO APEx Guidelines and RO-ILS to Medical Malpractice in Radiation Oncology

Evaluation of Biologically Equivalent Dose Escalation and Patient Outcomes Among International Randomized Controlled Trials of Conventionally Fractionated and Hypofractionated Radiation Therapy: A Meta-Analysis of 6800 Patients

Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM

Preliminary Results of Radiation Therapy Oncology Group 97-03: A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck

Type 2 Diabetes Mellitus, Oral Antihyperglycemics, Insulin Use, and Outcomes Among Men Receiving Radiation Therapy for Prostate Cancer

The Need for Androgen Deprivation Therapy in Patients With Intermediate-Risk Prostate Cancer Treated With Dose-Escalated External Beam Radiation Therapy

Effects of Time to Treatment on Biochemical and Clinical Outcomes for Patients With Prostate Cancer Treated With Definitive Radiation

Quality Adjusted Survival Comparing Standard Versus Hypofractionated Radiation Therapy in the Treatment of Prostate Cancer

Clinical Outcomes for Patients With Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiation Therapy or Radical Prostatectomy: A Comparative Analysis

Dosimetric and Clinical Predictors of Long-Term Toxicity in Patients Undergoing Hypofractionated Prostate Radiation Therapy: Results From a Randomized Phase 3 Trial

Efficacy of Pulsed Low-Dose-Rate Reirradiation: Results From a Phase 1 Clinical Trial

Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer

CT-MRI Fusion Uncertainty in Prostate Treatment Planning for Different Image Guidance Techniques

Men’s Health Supplement Use and Outcomes Among Men Receiving Definitive IMRT for Localized Prostate Cancer

A Multi-institutional Phase 2 Trial Assessing Quality of Life (QOL) After Electromagnetic Transponder Guided Prostate Stereotactic Body Radiation Therapy (SBRT)

Phase I Study of Pulsed Low Dose-Rate Reirradiation: A Dose-Escalation Study to Establish Maximum Tolerated Dose

Long-term Patient Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated IMRT Radiation Therapy for Localized Prostate Cancer

Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer

Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG Oncology/RTOG 9202

Nadir Prostate-Specific Antigen After Neoadjuvant Androgen Suppression (AS) in Prostate Cancer Patients Receiving Short-term AS and Radiation Therapy: Pooled Analysis of Four NRG Oncology/RTOG Randomized Clinical Trials

A Novel Methodology to Predict Late Urinary Toxicity Following Prostate Radiation Therapy-based on Bladder Wall Dosimetry

Recursive Partitioning Analysis of Intermediate Risk Prostate Cancer Patients Identifies Subgroup Risk Categories

Suchergebnisse filtern